Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist
AssigneeAmal Therapeutics SA
InventorsMadiha DEROUAZI, Elodie BELNOUE
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmal Therapeutics SA
InventorsMadiha DEROUAZI, Elodie BELNOUE
Estimating the term…
The present invention provides a novel complex comprising a) a cell penetrating peptide, b) at least one antigen or antigenic epitope, and c) at least one TLR peptide agonist, wherein the components a)-c) are covalently linked. Moreover, the present invention also provides a nucleic acid encoding such a complex, wherein the complex is a peptide or a protein. Such a nucleic acid may be comprised by a vector, and such a vector may be comprised by a host cell. In particular, compositions, such as a pharmaceutical compositions and vaccines are provided, which may be useful for example in the prevention and/or treatment of a diseases and/or a disorder including cancer, hematological disorders, infectious diseases, autoimmunity disorders and transplant rejections.
A complex comprising:
A method for treating cancer or initiating, enhancing or prolonging an anti-tumor-response in a subject in need thereof comprising administering to the subject a complex comprising:
A method for treating cancer and/or a hematological disorder, preferably a malignant neoplasm of the brain or a malignant neoplasm of lymphoid, hematopoietic and related tissue in a subject in need thereof, most preferably glioblastoma, comprising administering to the subject a complex comprising:
Dependencies are inferred from the claim text.